Q2 2026 13F · SEC CIK 1963764
Slotnik Capital, LLC
Hedge fundFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $359.4M
- Reported positions
- 26
- Holdings vs S&P 500, 3 yrs
- —
- Assets under management
- $415.8M
Slotnik Capital, LLC is a hedge fund that reported 26 positions worth $359.4M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Penumbra, Inc. (PEN, 11.7%), Taylor Morrison Home Corp (TMHC, 10.7%), Apogee Therapeutics Inc (APGE, 9.6%).
Slotnik Capital, LLC holdings all 26 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| PENPenumbra, Inc. | 11.7% | +31.7% | $42.0M |
| TMHCTaylor Morrison Home Corp | 10.7% | — | $38.4M |
| APGEApogee Therapeutics Inc | 9.6% | — | $34.6M |
| KVUEKenvue Inc | 8.7% | +89.6% | $31.2M |
| GSATGlobalstar Inc | 7.9% | — | $28.5M |
| GTLSChart Inds Inc | 7.6% | -41.4% | $27.2M |
| NUVLNuvalent Inc | 7.2% | — | $25.9M |
| TECHBio-Techne Corp | 4.0% | — | $14.6M |
| WBDWarner Bros Discovery Inc | 3.6% | -18.4% | $12.8M |
| WBSWebster Finl Corp | 3.3% | -43.4% | $11.8M |
| WESWestern Midstream Partners LP | 3.2% | +0.0% | $11.5M |
| ARISAris Mining Corporation | 2.9% | +0.0% | $10.4M |
| ROKURoku Inc | 2.6% | — | $9.4M |
| LBRDALiberty Broadband Corp | 2.6% | -33.1% | $9.4M |
| BF-ABrown Forman Corp | 2.5% | — | $9.1M |
| ACAArcosa Inc | 1.8% | — | $6.5M |
| RAMPLiveramp Holdings Inc | 1.6% | — | $5.8M |
| NSCNorfolk Southn Corporation | 1.6% | +17.6% | $5.7M |
| AVOMission Produce Inc | 1.4% | -45.1% | $5.0M |
| ADArray Digital Infrastructure | 1.3% | — | $4.5M |
| BZHBeazer Homes USA Inc | 1.2% | — | $4.3M |
| RNAAtrium Therapeutics Ord | 0.9% | +31.3% | $3.2M |
| SYNASynaptics Inc | 0.6% | — | $2.2M |
| BIOBio Rad Labs Inc | 0.6% | — | $2.2M |
| OLPXOlaplex Holdings, Inc. | 0.6% | — | $2.1M |
| RKTRocket Cos Inc | 0.3% | +0.0% | $1.2M |
What Slotnik Capital, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
- TMHC Taylor Morrison Home Corp10.7% of 13F
- APGE Apogee Therapeutics Inc9.6% of 13F
- GSAT Globalstar Inc7.9% of 13F
- NUVL Nuvalent Inc7.2% of 13F
- TECH Bio-Techne Corp4.0% of 13F
- ROKU Roku Inc2.6% of 13F
- BF-A Brown Forman Corp2.5% of 13F
- ACA Arcosa Inc1.8% of 13F
Added to
- KVUE Kenvue Inc+89.6% shares
- PEN Penumbra, Inc.+31.7% shares
- RNA Atrium Therapeutics Ord+31.3% shares
- NSC Norfolk Southn Corporation+17.6% shares
Reduced
- AVO Mission Produce Inc-45.1% shares
- WBS Webster Finl Corp-43.4% shares
- GTLS Chart Inds Inc-41.4% shares
- LBRDA Liberty Broadband Corp-33.1% shares
- WBD Warner Bros Discovery Inc-18.4% shares
Sold out
- MASI Masimo Corpwas 12.7%
- TERN Terns Pharmaceuticals Incwas 6.6%
- SLAB Silicon Laboratories Incwas 4.1%
- ACLX Arcellx Incwas 4.0%
- LBRDK Liberty Broadband Corpwas 3.9%
- TPH Tri Pointe Homes Incwas 3.7%
- UNF Unifirst Corp Masswas 2.6%
- APLS Apellis Pharmaceuticals Incwas 1.6%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- —
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $359.4M | 26 |
| Q1 2026 | $336.6M | 24 |
| Q4 2025 | $365.2M | 28 |
| Q3 2025 | $277.4M | 23 |
| Q2 2025 | $248.2M | 20 |
| Q1 2025 | $202.1M | 20 |
| Q4 2024 | $219.3M | 16 |
| Q3 2024 | $284.3M | 18 |
| Q2 2024 | $194.9M | 17 |
| Q1 2024 | $154.8M | 15 |
| Q4 2023 | $144.1M | 13 |
Questions about Slotnik Capital, LLC's portfolio
What stocks does Slotnik Capital, LLC own?
Slotnik Capital, LLC's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 26 positions worth $359.4M. The largest are Penumbra, Inc. (PEN) at 11.7%, Taylor Morrison Home Corp (TMHC) at 10.7%, Apogee Therapeutics Inc (APGE) at 9.6%, Kenvue Inc (KVUE) at 8.7% and Globalstar Inc (GSAT) at 7.9%.
What did Slotnik Capital, LLC buy last quarter?
In Q2 2026, Slotnik Capital, LLC added a new position in Taylor Morrison Home Corp (TMHC), a new position in Apogee Therapeutics Inc (APGE), a new position in Globalstar Inc (GSAT), a new position in Nuvalent Inc (NUVL), a new position in Bio-Techne Corp (TECH), Kenvue Inc (KVUE) (+89.6% shares), Penumbra, Inc. (PEN) (+31.7% shares) and Atrium Therapeutics Ord (RNA) (+31.3% shares), compared with its Q1 2026 filing.
What did Slotnik Capital, LLC sell last quarter?
In Q2 2026, Slotnik Capital, LLC sold all of Masimo Corp (MASI), sold all of Terns Pharmaceuticals Inc (TERN), sold all of Silicon Laboratories Inc (SLAB), sold all of Arcellx Inc (ACLX), sold all of Liberty Broadband Corp (LBRDK), Mission Produce Inc (AVO) (-45.1% shares), Webster Finl Corp (WBS) (-43.4% shares) and Chart Inds Inc (GTLS) (-41.4% shares), compared with its Q1 2026 filing.
When is Slotnik Capital, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Slotnik Capital, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Slotnik Capital, LLC manage?
Slotnik Capital, LLC reported $415.8M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $359.4M.